(Q53193315)

12 May 2018

title

Role of FDG-PET as a biological marker for predicting the hypoxic status of tongue cancer. (English)

1 reference

12 May 2018

Fluorodeoxyglucose Positron Emission Tomography

main subject

hypoxia

0 references

1 reference

7

Soon Yuhl Nam

1 reference

12 May 2018

Kyung-Ja Cho

3

object named as

Kyung-Ja Cho

1 reference

12 May 2018

Jong-Lyel Roh

5

object named as

Jong-Lyel Roh

1 reference

12 May 2018

author name string

Myung Woul Han

1

1 reference

12 May 2018

Hee Jin Lee

2

1 reference

12 May 2018

Jae Seung Kim

4

1 reference

12 May 2018

Seung-Ho Choi

6

1 reference

12 May 2018

Sang Yoon Kim

8

1 reference

12 May 2018

publication date

3 November 2011

1 reference

12 May 2018

published in

Head & Neck

1 reference

12 May 2018

volume

34

1 reference

12 May 2018

issue

10

1 reference

12 May 2018

page(s)

1395-1402

1 reference

12 May 2018

HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers

cites work

1 reference

Expression of hypoxia-inducible factor-1 alpha (HIF-1alpha) in patients with the gallbladder carcinoma.

21 January 2018

1 reference

High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer

21 January 2018

1 reference

The prognostic value of hypoxia markers in T2-staged oral tongue cancer

21 January 2018

1 reference

Role of hypoxia in the hallmarks of human cancer

21 January 2018

1 reference

Hypoxia, HIF1 and glucose metabolism in the solid tumour

21 January 2018

1 reference

Molecular imaging of hypoxia with radiolabelled agents

21 January 2018

1 reference

Molecular imaging of cancer: evaluating characters of individual cancer by PET/SPECT imaging

21 January 2018

1 reference

Modeling acute and chronic hypoxia using serial images of F18-FMISO PET.

21 January 2018

1 reference

Pharmacokinetic analysis of hypoxia (18)F-fluoromisonidazole dynamic PET in head and neck cancer

21 January 2018

1 reference

Radiopharmaceuticals in preclinical and clinical development for monitoring of therapy with PET

21 January 2018

1 reference

Utility of FMISO PET in advanced head and neck cancer treated with chemoradiation incorporating a hypoxia-targeting chemotherapy agent

21 January 2018

1 reference

Positron Emission Tomography Imaging of Hypoxia

21 January 2018

1 reference

PET monitoring of therapy response in head and neck squamous cell carcinoma

21 January 2018

1 reference

Combined uptake of [18F]FDG and [18F]FMISO correlates with radiation therapy outcome in head-and-neck cancer patients.

21 January 2018

1 reference

FDG uptake, a surrogate of tumour hypoxia?

21 January 2018

1 reference

Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage.

21 January 2018

1 reference

2-[18F]-2-deoxy-D-glucose (FDG) uptake in human tumor cells is related to the expression of GLUT-1 and hexokinase II.

21 January 2018

1 reference

18F-FDG PET findings and GLUT-1 expression in IPMNs of the pancreas

21 January 2018

1 reference

Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-D-glucose uptake by positron emission tomography in colorectal cancer

21 January 2018

1 reference

Carbonic anhydrase IX expression correlates with FDG uptake by primary non-small cell lung cancer

21 January 2018

1 reference

Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Comparison with the hypoxic tracer (14)C-EF3 in animal tumor models

21 January 2018

1 reference

18F-FDG-PET of musculoskeletal tumors: a correlation with the expression of glucose transporter 1 and hexokinase II.

21 January 2018

1 reference

Expression of Glut-1 in primary and recurrent head and neck squamous cell carcinomas, and compared with 2-[18F]fluoro-2-deoxy-D-glucose accumulation in positron emission tomography

21 January 2018

1 reference

The maximum uptake of (18)F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1alpha and GLUT-1 in non-small cell lung cancer

21 January 2018

1 reference

Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-D-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy

21 January 2018

1 reference

Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose

21 January 2018

1 reference

Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer

21 January 2018

1 reference

SUVmax of FDG-PET correlates with the effects of neoadjuvant chemoradiotherapy for oral squamous cell carcinoma

21 January 2018

1 reference

Prognostic value of 18F-FDG PET in patients with head and neck squamous cell cancer

21 January 2018

1 reference

FDG-PET prediction of head and neck squamous cell cancer outcomes

21 January 2018

1 reference

Prognostic Significance of Tumor Hypoxia Inducible Factor–1α Expression for Outcome After Radiotherapy in Oropharyngeal Cancer

21 January 2018

1 reference

Quantifying tumour hypoxia by PET imaging--a theoretical analysis.

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Initial results of hypoxia imaging using 1-alpha-D: -(5-deoxy-5-[18F]-fluoroarabinofuranosyl)-2-nitroimidazole ( 18F-FAZA)

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

FDG--a marker of tumour hypoxia? A comparison with [18F]fluoromisonidazole and pO2-polarography in metastatic head and neck cancer

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HED.21945

1 reference

12 May 2018

1 reference

12 May 2018